Credit memo example: Petco first lien rated 5, 7 in a downside

A private credit associate asks Compound for an investment committee credit memo on a first-lien loan held by a public BDC: the loan's terms from Palmer Square Capital BDC's schedule of investments checked against Petco's credit agreement, lender EBITDA, a lender case and a downside case, the document terms that decide recovery, relative value and an internal risk rating, in a Word memo with the workbook behind it.

Compound Research · Updated Nov 19, 2026 · 15 min read

Short answer

A credit memo makes the case for a loan to the investment committee: terms, earnings, a downside, documents, recovery, relative value and a risk rating. Compound's memo on Petco's first-lien term loan recommends a $10.0 million hold at up to 100.50, rated 5 of 10, with 47.8% recovery at a 4.5x distressed multiple.

Try it now
On this page (10)
  1. 1. Page one: the recommendation and the loan's terms
  2. 2. Adjusted EBITDA, each addback, and lender EBITDA
  3. 3. The lender case and the downside case
  4. 4. The documents: EBITDA definition, incremental debt and priming protections
  5. 5. Recovery at a 4.5x distressed multiple
  6. 6. Relative value against the BDC's book and the leveraged loan market
  7. 7. Key risks, mitigants and the internal risk rating
  8. 8. What the public filings cannot tell you
  9. 9. Our view
  10. 10. FAQ

Compound’s credit memo recommends that the committee approve a $10.0 million position in Petco Health and Wellness Company’s first-lien term loan at a price of up to 100.50, with an internal risk rating of 5 (Acceptable). The loan pays Term SOFR plus 4.25%, matures in February 2031 and ranks behind only a $546 million ABL on current assets. Pro forma net leverage is 2.84x on the company’s Adjusted EBITDA and 3.29x on the memo’s lender EBITDA, and liquidity is $706.1 million.

The memo states the case against on its first page. Lease-adjusted leverage is 6.07x, the documents allow $687 million of new pari passu debt, and base-case recovery is 47.8%. In the downside case leverage peaks at 5.34x, fixed charges are covered 1.03x, and the rating falls to 7 (Special mention). Those results are the model’s, under assumptions the workbook labels as the analyst’s, and they are not a view on Petco’s credit or a price to trade at.

You are an associate at a private credit fund, and the committee wants a memo on a broadly syndicated first-lien loan. You need the loan’s terms from the documents, an earnings figure you would lend against, a downside you can defend, the clauses that decide what you recover, and a rating. We asked Compound to write that memo on a real loan from public filings. It ran on November 19, 2026 and returned a Word memo of eight tables, an Excel workbook of eight sheets and a short written answer.

What the memo and workbook show:

  • The loan. Palmer Square Capital BDC’s 10-Q for September 30, 2026 lists Petco’s first-lien term loan at S + 4.25%, 8.32% all-in, due 1/31/2031, with par of $2,286,562 and fair value of $2,292,679, a 100.27 mark. The credit agreement supplies the 0.00% floor the schedule leaves out, and a maturity two days later.
  • The earnings base. LTM Adjusted EBITDA is $424.4 million, of which $93.9 million is addbacks above EBITDA. Taking out Petco’s 50% share of its Mexico joint venture and a $6.8 million tariff refund leaves lender EBITDA of $366.0 million.
  • The two cases. The lender case delevers to 2.16x by FY2030E. The downside peaks at 5.34x, and liquidity stays at $586.7 million or more.
  • The documents. Run-rate cost savings are added back with no cap, and the free-and-clear incremental starts at $543 million. Subordination needs every lender’s consent.
  • Recovery and value. A 4.5x distressed multiple recovers 47.8% for the term loan, and 33.3% if Petco first raises the full $618 million free-and-clear incremental. The spread matches the median of 223 first-lien loans in the BDC’s book and pays 92 bps over B-rated loans in the LSTA index.

The BDC schedule, Petco’s credit agreement, indenture, ABL agreement, 10-K, 10-Q and earnings release come from SEC EDGAR and the company’s earnings documents. Historical statements, the share price and the share count come from Compound’s company financial data, and loan interest is priced off the SOFR forward curve at the November 19, 2026 close. The leveraged loan index, new-issue spreads and the Moody’s upgrade came from a web search, because the stored data does not carry them.

Prompt to try

“I am a private credit associate and need an investment committee credit memo on a real first-lien loan. From the latest 10-K or 10-Q schedule of investments of a public BDC, pick one first-lien senior secured loan whose borrower is itself an SEC filer, so its financials are public, and take the loan's spread, floor, maturity, par, cost and fair value from that schedule and the terms from the borrower's credit agreement on EDGAR. Write a Word memo of about six pages for a credit committee: the recommendation and key terms on page one; the business and its position; historical financials with Adjusted EBITDA and each addback; a lender case and a downside case with leverage, interest and fixed charge coverage and liquidity; the structure, collateral, covenants and the document terms that matter most to recovery, including the EBITDA definition, incremental debt capacity and any protections against priming or asset transfers; a recovery analysis at a distressed multiple; relative value against the BDC's other first-lien loans by spread and against the leveraged loan market; the key risks, each with a mitigant; and an internal risk rating with the reason. Build the supporting numbers in an Excel workbook with every input on an Assumptions sheet with one column that says where it came from: a cited source, or "analyst assumption" for a figure I would set myself, with the reason. Every output must be a live formula. Add a Sources sheet listing each data source, what it gave and its date. Use the stored public data wherever it has the figure, and web search only for what it lacks. Deliver the Word memo and the Excel workbook, and cite every sourced figure.”

Try this prompt free →

That is the request as we sent it, without its closing line, which asks that no name or email be put in the files.

Page one: the recommendation and the loan’s terms

The memo opens with the decision, the price limit, the rating and the main argument against, in one paragraph. The key terms table below it takes the price and position from the BDC schedule and everything else from Petco’s own documents, and it shows both maturity dates where the two disagree.

Petco_1L_IC_Credit_Memo.docx

Recommendation: approve a $10.0 million position at up to 100.50

We recommend approving a $10.0 million purchase of Petco’s first-lien term loan (Term SOFR + 4.25%, 0.00% floor, due Feb 2, 2031) at a price of up to 100.50, with an internal risk rating of 5 (Acceptable). Palmer Square Capital BDC carries the loan at 100.27, it pays a current coupon of about 8.45%, and only a $546 million ABL on current assets ranks ahead of it. Pro forma net leverage is 2.84x on company Adjusted EBITDA and 3.29x on our lender EBITDA, liquidity is $706.1 million, and the lender case delevers to 2.16x on lender EBITDA by FY2030E. The case against is real: lease-adjusted leverage is 6.07x, comparable sales fell in FY2025, the documents permit $687 million of new pari passu debt, and base-case recovery is 47.8%. At S+425, about 92 bps over B-rated loans in the LSTA index and in line with the PSBD first-lien median, the spread pays for those risks at a $10.0 million hold.

  • Facility: 2026 Term Loans under the First Lien Credit Agreement dated Mar 4, 2021, refinanced by the Second Amendment of Feb 2, 2026; $900 million funded
  • Outstanding: $897.8 million at Aug 1, 2026; $822.8 million after the $75.0 million voluntary prepayment in Sept 2026
  • Floor: 0.00% Term SOFR floor and 1.00% base rate floor; the PSBD schedule says its loans carry floors but gives no level
  • Maturity: Feb 2, 2031 under the credit agreement; the PSBD schedule shows 1/31/2031
  • Ranking and collateral: First-priority lien on Fixed Asset Collateral (equipment, real estate, intellectual property, subsidiary equity) shared pari passu with $600 million of 8.25% senior secured notes due Feb 1, 2031; second-priority lien on ABL current assets
  • Financial covenant: None on the term loan; the ABL tests a fixed charge coverage ratio of 1.00 to 1.00 only in a Covenant Trigger Event
  • BDC reference position: PSBD at Sept 30, 2026: par $2,286,562, amortized cost $2,234,811, fair value $2,292,679; rate 8.32% (S + 4.25%)
  • Proposed position: $10.0 million at up to 100.50; current cash yield 8.41% at that price
The opening paragraph of Compound's IC memo and eight of the fourteen rows of its key terms table, unedited apart from the cut. In the memo the terms are set out as a two-column table.

Compound picked the loan from Palmer Square Capital BDC’s 10-Q, filed on November 4, 2026, because the borrower is itself an SEC registrant (Nasdaq: WOOF). The schedule line gives the spread, the all-in rate, the maturity, par, cost and fair value. Its footnotes add that the position is a non-qualifying asset held in the BDC’s CLO I. It does not give the floor: a footnote says only that each variable-rate loan is subject to one. Compound took the 0.00% Term SOFR floor from the Second Amendment to Petco’s First Lien Credit Agreement, filed on Form 8-K on February 2, 2026.

The two sources also disagree on the maturity. The schedule shows January 31, 2031, and Petco’s 10-Q for the quarter ended August 1, 2026 gives February 2, 2031. The workbook carries both and computes the gap, minus two days, so a reviewer sees which date each figure uses. The memo uses the credit agreement’s date in the recommendation and shows the schedule’s beside it in the terms.

Petco_1L_Credit_Model.xlsx
G12fx=E12/$E$16
BCDEFG
5Instrument8/1/2026AdjustmentPro formax LTM Adj. EBITDAx LTM lender EBITDA
6ABL revolver ($546M commitment)0.00.00.00.00x0.00x
72026 first-lien term loan897.8(75.0)822.81.94x2.25x
88.250% senior secured notes600.00.0600.01.41x1.64x
9Total first-lien secured debt ($M)1,497.8(75.0)1,422.83.35x3.89x
10Total debt ($M)1,497.8(75.0)1,422.83.35x3.89x
11(-) Cash and cash equivalents(293.5)75.0(218.5)
12Net debt ($M)1,204.30.01,204.32.84x3.29x
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
The capital structure from Compound's Capitalization tab, rows 5 to 12, without the pricing and maturity columns. $ millions at August 1, 2026, pro forma for the September 2026 prepayment.

The September prepayment comes out of both debt and cash, so net debt stays at $1,204.3 million. The $10.0 million hold is, in the workbook’s note, about four times the BDC’s position and under 1.5% of the $822.8 million term loan, “so the position stays liquid”. The 100.50 cap “keeps yield above 8.2% at current SOFR forwards and limits soft-call give-up”.

Adjusted EBITDA, each addback, and lender EBITDA

Petco’s LTM Adjusted EBITDA of $424.4 million is $93.9 million of addbacks on top of $330.5 million of EBITDA. The memo accepts stock compensation and the recurring other costs, takes out the 50% share of the Mexico joint venture’s EBITDA and a one-off tariff refund, and lends against $366.0 million, 13.8% less than the company’s figure.

Petco_1L_Credit_Model.xlsx
H40fx=SUM(H37:H39)
BCDEH
4FY2023AFY2024AFY2025ALTM Q2 FY2026
23EBITDA ($M)250.6220.4317.1330.5
24(+) Equity-based compensation81.950.232.732.5
25(-) Other non-operating income(4.7)(4.8)0.00.0
26(+) Mexico joint venture EBITDA, 50% share38.241.646.151.6
27(+) Acquisition and divestiture-related costs0.03.70.00.0
28(+) Other costs (restructuring, severance, legal)35.225.412.29.8
29Adjusted EBITDA, company definition ($M)401.1336.5408.2424.4
30Adjusted EBITDA as reported401.1336.5408.2424.4
31Difference: rebuilt less reported0.00.00.00.0
32Adjusted EBITDA margin %6.4%5.5%6.8%7.1%
33Total addbacks above EBITDA150.6116.291.093.9
34Addbacks as % of Adjusted EBITDA37.5%34.5%22.3%22.1%
37Adjusted EBITDA, company definition401.1336.5408.2424.4
38(-) Mexico JV EBITDA (not cash to the borrower)(38.2)(41.6)(46.1)(51.6)
39(-) Net tariff refund benefit (non-recurring, Q2 FY2026)0.00.00.0(6.8)
40Lender EBITDA ($M)362.9294.9362.0366.0
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
The Adjusted EBITDA reconciliation and the lender adjustments from Compound's Historicals tab, rows 23 to 40, without the two half-year columns. $ millions; fiscal years end on the Saturday nearest January 31. Row 31 checks the rebuilt figure against the one Petco reports.

The reconciliation rebuilds Petco’s reported Adjusted EBITDA from net income, line by line, and row 31 ties it to zero in every period. Addbacks fell from 37.5% of Adjusted EBITDA in FY2023 to 22.1%, as stock compensation fell from $81.9 million to $32.5 million.

LTM Q2 FY2026: EBITDA to company Adjusted EBITDA to lender EBITDA

$ millions, twelve months to August 1, 2026. The first three steps are Petco's addbacks; the last two are the memo's adjustments

EBITDA330.5Equity-based compensation+32.5Mexico JV EBITDA, 50% share+51.6Other costs+9.8Remove Mexico JV EBITDA-51.6Remove tariff refund-6.8Lender EBITDA13.8% below the company's $424.4M366Axis starts at 316.415

From Compound's Historicals tab, column H. Petco's addbacks are from its 10-K for fiscal 2025 and its second-quarter 2026 earnings release.

The memo explains each call in one paragraph.

Petco_1L_IC_Credit_Memo.docx

Adjusted EBITDA of $424 million rests on $94 million of addbacks and $52 million of joint venture EBITDA

Addbacks above EBITDA have fallen from 37.5% of Adjusted EBITDA in FY2023 to 22.1% on an LTM basis, and we accept most of them. Equity-based compensation ($32.5 million LTM) is non-cash. Other costs recur every year (FY2025: $9.7 million of severance and $2.5 million of legal matters), so both projection cases charge $10 million a year of them against cash flow. The Mexico joint venture line adds 50% of the venture’s operating results even though Petco accounts for it under the equity method and receives cash only through dividends; we remove it. We also remove the $6.8 million of net IEEPA tariff refunds in Q2 FY2026, which management itself excludes from its $115.4 million normalized Q2 figure. LTM lender EBITDA is $366.0 million, 13.8% below the company’s $424.4 million.

The paragraph under Table 2 of Compound's IC memo, unedited.

The joint venture adjustment moves the ratios. Petco adds back 50% of the Mexico venture’s EBITDA, $51.6 million over the last twelve months, which a lender reaches only through dividends. The memo leaves it out of earnings, counts the stake as a separate asset in recovery, and net leverage rises from 2.84x to 3.29x.

With leases, LTM rent is $413.1 million and lender EBITDAR $779.0 million. Rent capitalized at 8x, the workbook’s “conventional 8x rent capitalization used by rating agencies for retailers”, gives lease-adjusted leverage of 6.07x.

The lender case and the downside case

The lender case holds the margin at 7.0%, grows sales 1.0% to 1.5% a year and prepays the term loan with half of free cash flow, reaching 2.16x by FY2030E. The downside cuts sales by 4.0% and 3.0% in two years and the margin to 5.0%, adds 100 bps to SOFR, and repays nothing: leverage peaks at 5.34x in FY2028E and fixed charges are covered 1.03x.

Petco_1L_Credit_Model.xlsx
F117fx=F104/F74
BCDEFGH
4LTM Q2 FY2026FY2026EFY2027EFY2028EFY2029EFY2030E
7LENDER CASE
14Lender EBITDA ($M)366.0363.7371.1376.0381.0386.0
26Free cash flow ($M)81.381.784.190.992.8
44Net debt ($M)1,204.31,183.91,102.11,018.0927.1834.3
57Net leverage, lender EBITDA3.29x3.26x2.97x2.71x2.43x2.16x
59Interest coverage: lender EBITDA / cash interest3.07x2.98x3.04x3.21x3.37x3.54x
60Fixed charge coverage: (lender EBITDA - capex - cash taxes) / (interest + amortization)1.88x1.75x1.79x1.85x1.94x1.99x
62Liquidity: cash plus available ABL ($M)706.1716.3757.2799.2844.7891.1
67DOWNSIDE CASE
74Lender EBITDA ($M)366.0346.5268.2234.2242.4252.3
86Free cash flow ($M)68.4(23.1)(30.8)2.913.0
104Net debt ($M)1,204.31,196.71,219.81,250.61,247.61,234.6
117Net leverage, lender EBITDA3.29x3.45x4.55x5.34x5.15x4.89x
119Interest coverage: lender EBITDA / cash interest3.07x2.84x2.04x1.80x1.87x1.95x
120Fixed charge coverage: (lender EBITDA - capex - cash taxes) / (interest + amortization)1.88x1.64x1.20x1.03x1.10x1.18x
122Liquidity: cash plus available ABL ($M)706.1640.5617.4586.7589.6602.6
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
Selected rows of both cases from Compound's Projections tab, $ millions. The rows for sales, rent, cash interest, taxes, capex and the debt roll-forward are left out. FY2026E is the full fiscal year; its cash flow opens at the August 1, 2026 balance sheet.

The lender case starts FY2026E at $422.5 million of Adjusted EBITDA, the midpoint of Petco’s $415 million to $430 million guidance, and charges the $122 million of net interest the company guided to. Term loan interest is priced off the SOFR forward curve at the November 19, 2026 close, which starts at 4.20%, plus the 4.25% spread. Capex runs at $140 million to $150 million a year, and the joint venture share is deducted every year.

The downside is an analyst assumption with a stated reason: second-half comparable sales turn negative in FY2026, followed by “a two-year consumer-led decline”. Free cash flow turns negative by $23.1 million in FY2027E and $30.8 million in FY2028E, and net debt rises to $1,250.6 million. The case also cuts ABL availability by 15% against the August 1, 2026 level, and liquidity bottoms at $586.7 million.

Net leverage on lender EBITDA, lender case and downside case

Net debt over lender EBITDA, in times. LTM is the twelve months to August 1, 2026, pro forma

2.0x3.0x4.0x5.0x6.0xFY2026EFY2028EFY2030EDownside caseLender case

Compound's Projections tab, rows 57 and 117.

The memo finds the downside’s binding risk in the refinancing.

Petco_1L_IC_Credit_Memo.docx

Free cash flow is the lender EBITDA build (after cash interest, taxes, capex, working capital and recurring other costs), not the reported operating cash flow less capex in the LTM column, which benefited from inventory release. In the lender case net debt falls from $1,204.3 million to $834.3 million and net leverage on lender EBITDA reaches 2.16x by FY2030E, so the Feb 2031 maturities refinance at about 3.2x gross. In the downside, free cash flow turns negative in FY2027E and FY2028E, leverage peaks at 5.34x and fixed charge coverage bottoms at 1.03x, yet liquidity never falls below $586.7 million and stays far above the ABL covenant trigger. The binding downside risk is refinancing: the $546 million ABL matures Mar 29, 2029 and $1,422.8 million of first-lien debt would face Feb 2031 maturities at about 4.9x lender leverage.

The paragraph under Table 3 of Compound's IC memo, unedited.

The documents: EBITDA definition, incremental debt and priming protections

The term loan has no financial covenant, its EBITDA definition adds back run-rate savings with no cap, and Petco can add $687 million of pari passu debt today, 48% of existing first-lien debt. Against that, subordinating the loan or its liens needs every lender, and there are blockers on intellectual property transfers and guarantor releases, each with a carve-out.

Petco_1L_IC_Credit_Memo.docx

The documents block uptiers and IP drop-downs but leave $687 million of pari passu debt capacity

EBITDA definition. Adds back run-rate cost savings expected within 24 months with no cap, addbacks of the type in the lender presentation or any quality of earnings report, business optimization costs, and joint venture net income up to Petco’s ownership share. Uncapped and forward-looking; covenant EBITDA can run well above our lender EBITDA and inflates every ratio basket.

Incremental debt. Free-and-clear amount is the greater of 100% of Closing Date EBITDA ($543 million) and TTM EBITDA, plus voluntary prepayments not funded with long-term debt; unlimited pari passu debt at or below 3.00x first-lien net leverage. $618 million free-and-clear today, including the Sept 2026 prepayment, plus about $69 million of ratio capacity: $687 million, 48% of existing first-lien debt.

Most favored nation. 75 bps cushion, but debt incurred more than six months after the Second Amendment, debt below 50% of EBITDA and ratio-based debt are excluded. Effectively no yield protection after Aug 2026.

Liability management. Subordinating the obligations or the liens needs every lender before a bankruptcy default; changes to pro rata sharing need each affected lender; no material IP may go to an unrestricted subsidiary unless for a bona fide business purpose; a guarantor that becomes non-wholly owned is released only for fair value and a bona fide purpose. Serta, J.Crew and Chewy blockers are present, but the J.Crew carve-out and the bankruptcy fall-away weaken them.

Four of the seven rows of Table 4 in Compound's IC memo, unedited apart from the cut. The memo sets out each provision, what the documents say and its assessment in three columns; here each row is one paragraph.

Each is cited to the conformed credit agreement filed with the February 2, 2026 8-K, and the capacity is a live calculation.

Petco_1L_Credit_Model.xlsx
E45fx=E43+E44
BE
42DEBT CAPACITY UNDER THE CREDIT AGREEMENT
43Fixed Incremental Amount: free-and-clear plus voluntary prepayments ($M)618.0
44Ratio Amount headroom to 3.00x first-lien net leverage ($M)68.9
45Total pari passu incremental capacity ($M)686.9
46Incremental capacity as % of existing first-lien debt48.3%
47First-lien net leverage if capacity is fully used4.46x
48General lien basket, may be pari passu ($M)271.5
49General investment basket ($M)271.5
50General restricted payment basket ($M)135.8
51Unlimited restricted payments test met (net leverage at or below 2.50x)?No
52Unlimited investments test met (net leverage at or below 2.75x)?No
53Excess cash flow sweep % at current leverage50.0%
54Asset sale sweep % at current leverage100.0%
55ABL covenant trigger: excess availability floor ($M)54.6
56ABL availability cushion above trigger ($M)433.0
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
Debt capacity under the credit agreement from Compound's Capitalization tab, rows 42 to 56, unedited. $ millions.

The free-and-clear amount is $618.0 million: the $543 million Closing Date EBITDA, which is larger than trailing EBITDA today, plus the $75.0 million voluntary prepayment, which the agreement adds back to the basket. The ratio basket adds $68.9 million of headroom to 3.00x first-lien net leverage. If Petco used all of it, first-lien net leverage would be 4.46x. The general lien basket of $271.5 million may also be pari passu.

The tests for unlimited restricted payments (2.50x) and investments (2.75x) fail today at 2.84x, and the lender case clears 2.50x in FY2028E. The ABL’s springing 1.00x fixed charge test applies only below $54.6 million of excess availability, $433.0 million under today’s level, so a term lender gets no early warning. The credit agreement analysis page works through these definitions clause by clause on another borrower.

Recovery at a 4.5x distressed multiple

The memo values Petco at default on the downside trough, less a further 10%, at 4.5x. After administrative claims and a 60%-drawn ABL, the pari passu first lien recovers 47.8%. If Petco first raises the full free-and-clear incremental as pari passu debt, recovery falls to 33.3%.

Petco_1L_Credit_Model.xlsx
E24fx=MIN(1,E20/E23)
BE
5DISTRESSED VALUE
6Downside-case trough lender EBITDA (FY2027E to FY2030E)234.2
7(-) Further EBITDA decline at default(23.4)
8Distressed lender EBITDA ($M)210.8
9Distressed EV multiple4.5x
10Enterprise value of the restricted group ($M)948.4
11(+) Value of 50% Mexico JV stake, after haircut112.5
12Total distributable value ($M)1,060.9
13(-) Administrative and priority claims(53.0)
14Net distributable value ($M)1,007.9
16WATERFALL
17ABL claim at default327.6
18ABL recovery327.6
19ABL recovery %100.0%
20Value available to pari passu first-lien debt ($M)680.3
21Term loan claim at default822.8
22Senior secured notes claim600.0
23Total pari passu first-lien claims ($M)1,422.8
24First-lien term loan recovery % (base case)47.8%
25Term loan recovery ($M)393.4
29DILUTION CASE: FREE-AND-CLEAR INCREMENTAL USED BEFORE DEFAULT
30Fixed Incremental Amount available today ($M)618.0
31Share used before default100.0%
32Incremental pari passu debt ($M)618.0
33Total pari passu first-lien claims with incremental ($M)2,040.8
34First-lien term loan recovery % with incremental33.3%
35Recovery lost to dilution (percentage points)14.5
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
The distressed value, waterfall and dilution case from Compound's Recovery tab, rows 5 to 35, without the per-hold and implied-multiple rows. $ millions.

The trough is $234.2 million of lender EBITDA in the downside’s FY2028E, cut 10% to $210.8 million because “retail defaults typically show EBITDA well below plan”. At 4.5x the restricted group is worth $948.4 million. The 50% Mexico stake adds $112.5 million after a 50% haircut, because it is an illiquid minority interest “that may sit outside the collateral package”. Administrative and priority claims take 5%, and the ABL, assumed 60% drawn at default, recovers in full ahead of the term loan.

That leaves $680.3 million for $1,422.8 million of term loan and notes claims, which rank equally on the fixed asset collateral. The dilution case adds $618.0 million of incremental debt to the same class, and recovery drops by 14.5 percentage points. The model’s total value at default is 2.90x LTM lender EBITDA, a figure set by the downside case and the 4.5x multiple together.

Petco_1L_Credit_Model.xlsx
BCK
166G. RECOVERY ASSUMPTIONS (ANALYST)
167Further EBITDA decline at default versus downside-case trough10.00%Analyst assumption: default occurs after the downside trough deepens; retail defaults typically show EBITDA well below plan
168Distressed enterprise value multiple of lender EBITDA4.50xAnalyst assumption: below Petco's current market EV of about 5x lender EBITDA; specialty retail reorganizations clear at 4x to 5x
169Value multiple for the 50% Mexico JV stake5.00xAnalyst assumption: minority stake in a profitable JV, valued at a discount to the parent multiple
170Haircut to the Mexico JV stake value50.00%Analyst assumption: illiquid minority interest that may sit outside the collateral package
171Administrative and priority claims, % of distributable value5.00%Analyst assumption: professional fees, 503(b)(9) vendor and wage claims
172ABL drawn at default, % of commitment60.00%Analyst assumption: borrowers typically draw revolvers before filing; capped by a shrinking borrowing base
173Free-and-clear incremental used before default (dilution case)100.00%Analyst assumption: full use of the Fixed Incremental Amount as pari passu debt ahead of a liability management or default
177H. POSITION AND RELATIVE VALUE (ANALYST)
178Proposed hold size10.0Analyst assumption: about 4x PSBD's position; under 1.5% of the $822.8M term loan so the position stays liquid
179Maximum purchase price100.50Analyst assumption: keeps yield above 8.2% at current SOFR forwards and limits soft-call give-up
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
The recovery and position inputs from Compound's Assumptions tab, rows 166 to 179, with the unit column dropped. Every row is an analyst assumption with its reason; sourced inputs on the same sheet carry a citation instead.

The recovery is sensitive to both the multiple and the EBITDA at default, and the workbook runs a grid on the base-case claims.

Petco_1L_Credit_Model.xlsx
F41fx=MIN(1,MAX(0,((($C41*F$38)+$E$11)*(1-Assumptions!$C$171)-$E$18)/$E$23))
BCDEFGH
38Change in distressed EBITDA / distressed EBITDA ($M)EBITDA ($M)3.5x4.0x4.5x5.0x5.5x
39(30%)147.519%24%29%34%39%
40(15%)179.126%32%38%44%50%
410%210.834%41%48%55%62%
4215%242.441%49%57%65%73%
4330%274.049%58%67%76%85%
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
Term loan recovery by change in distressed EBITDA (rows) and distressed EV multiple (columns) from Compound's Recovery tab, rows 38 to 43, unedited. The 4.5x column at 0% is the base case.

At 3.5x recovery is 34%, and at 5.5x it is 62%. A 15% weaker EBITDA at default cuts the 4.5x figure to 38%. The same grid with full incremental dilution sits on the sheet below it. Our recovery analysis page runs a fuller waterfall by lien and collateral pool on a stressed borrower.

Relative value against the BDC’s book and the leveraged loan market

At S + 4.25% Petco sits at the median of 223 accruing floating-rate first-lien loans in the BDC’s book, and 110 of them pay more. It pays 92 bps over B-rated loans in the LSTA index and 118 bps over third-quarter new-issue buyout loans. The memo reads the premium as payment for specialty retail and lease intensity.

Petco_1L_Credit_Model.xlsx
E22fx=_xlfn.PERCENTRANK.INC($C$60:$C$286,Assumptions!$C$8)
BE
15PSBD FIRST-LIEN BOOK, SEPT 30, 2026
16Loans in the comparison set (count)223
17Simple average spread (bps)438
18Par-weighted average spread (bps)429
19Median spread (bps)425
2025th percentile spread (bps)350
2175th percentile spread (bps)500
22Petco percentile rank within the book43.6%
23Loans priced wider than Petco (count)110
24Petco less par-weighted average (bps)(4)
25Book fair value / par (% of par)91.01
26Petco fair value / par less book (points)9.25
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
Statistics for the PSBD first-lien book at September 30, 2026 from Compound's Relative Value tab, rows 15 to 26, unedited. The comparison set is listed position by position lower on the same sheet.

Compound linked every first-lien position in the BDC’s schedule into the workbook and computed the book’s statistics with live formulas. The interquartile range runs from 350 to 500 bps.

Spread over SOFR: Petco against the BDC's book and the loan market

Basis points. PSBD figures at September 30, 2026; LSTA index for the week ending November 12, 2026; new-issue buyout loans for the third quarter of 2026

LSTA index, BB loans240New-issue LBO loans, Q3 2026307Morningstar LSTA US Leveraged Loan Index312LSTA index, B loans333Petco 2026 term loan425PSBD first-lien book, median425PSBD first-lien book, par-weighted429LSTA index, CCC loans468

Compound's Relative Value tab, rows 30 to 37: Palmer Square Capital BDC 10-Q for September 30, 2026; Morningstar LSTA US Leveraged Loan Index statistics as published by Voya Investment Management; PitchBook LCD.

Petco_1L_IC_Credit_Memo.docx

S+425 matches the PSBD first-lien median and pays about 90 bps over B-rated loans

Within the PSBD book Petco is a median credit on spread: it ranks at the 43.6th percentile of 223 accruing floating-rate first-lien positions and 110 of them pay more. It is marked 9.25 points above the book’s 91.01 average price, which reflects a performing public borrower in a book that carries several stressed names. Against the market, Petco pays 92 bps over the LSTA B-loan average, 118 bps over Q3 2026 new-issue LBO loans, and 150 bps of spread per turn of net leverage against LCD’s 69 bps for buyouts. We read the premium as payment for specialty retail and lease intensity rather than mispricing. At the PSBD mark the three-year discounted spread is 416 bps and the yield about 8.36%, close to the 8.23% current yield on Petco’s own 8.250% secured notes.

The paragraph under Table 6 of Compound's IC memo, unedited.

The most direct comparison is Petco’s own 8.250% notes, which share the collateral, mature a day before the term loan and yield 8.23% at their 10-Q fair value of 100.25. Compound’s answer flags the sourcing of the market figures: the LSTA statistics were “read from a table image on Voya’s weekly page”, and the Moody’s upgrade “comes from a news article rather than Moody’s itself”.

Key risks, mitigants and the internal risk rating

The memo names six risks, each with a mitigant, and scores the credit on seven weighted factors. The weighted score of 5.8 maps to a rating of 5 (Acceptable). In the downside the score rises to 7.7 and the rating to 7 (Special mention), driven by leverage, fixed charge coverage and the diluted recovery.

Petco_1L_IC_Credit_Memo.docx

Six risks matter, and each has a mitigant we can underwrite

  • Lease-intensive costs: $413.1 million of LTM rent and 6.07x lease-adjusted leverage. Store leases can be shed in a restructuring and the fleet is being pruned, with 15 to 20 net closures guided for FY2026; EBITDAR covers interest plus rent 1.46x
  • Dilution from $687 million of pari passu capacity and an uncapped EBITDA definition. Recovery is sized at 33% with full dilution; the hold is capped at $10.0 million; material debt incurrence is reported on Form 8-K, giving time to exit near par
  • Refinancing: the ABL matures Mar 29, 2029 and the notes and term loan in Feb 2031. The lender case reaches 2.16x lender leverage by FY2030E; Petco refinanced its $1,500.0 million term loan in Feb 2026 and Moody’s upgraded it to B2
  • Floating rates: +100 bps adds $9.1 million of annual cash interest. Fixed-rate notes are 42% of first-lien debt and Petco holds cash flow hedges that cap part of its floating-rate debt; interest coverage is 3.07x
Four of the six rows of Table 7 in Compound's IC memo, each risk followed by its mitigant, unedited apart from the cut.

The other two are share loss to online and mass channels, against a services business of $1,025.1 million that grew 2.6% in FY2025 and about 300 veterinary hospitals, and liability management, against the blockers above and a $710.3 million equity market value that “gives shareholders value to protect”.

Petco_1L_Credit_Model.xlsx
H13fx=SUM(H6:H12)/G13
BCDEFGHI
5FactorCurrent metricCurrent scoreDownside metricDownside scoreWeightWeighted (current)Weighted (downside)
6Leverage: net leverage on lender EBITDA (x)3.29x65.34x1025%1.502.50
7Coverage: fixed charge coverage (x)1.88x61.03x815%0.901.20
8Liquidity: cash plus ABL availability ($M)706.12586.7410%0.200.40
9Recovery: first-lien term loan recovery (%)47.8%833.3%1010%0.801.00
10Equity cushion: market capitalization / EV (%)37.1%637.1%610%0.600.60
11Business position (qualitative)6720%1.201.40
12Documentation and structure (qualitative)6610%0.600.60
13Weighted score100%5.87.7
15Internal risk rating (1 to 10)57
16Rating categoryAcceptableSpecial mention
AssumptionsHistoricalsCapitalizationProjectionsRecoveryRelative ValueRisk RatingSources
The internal risk rating scorecard from Compound's Risk Rating tab, rows 5 to 16, unedited. Scale 1 (lowest risk) to 10 (loss); the downside column takes the worst metric across FY2026E to FY2030E.

The five quantitative factors score 2, 4, 6, 8 or 10 against bands set on the Assumptions sheet. Business position and documentation are judgments, and the workbook gives the reason for each score beside it. The weighted score maps to a rating through thresholds of 3.0, 4.5, 6.0 and 7.0, which the sheet explains as “a score of 6 on every factor describes a typical performing single-B credit”.

Petco_1L_IC_Credit_Memo.docx

Internal risk rating 5 (Acceptable), migrating to 7 in the downside

The 5.8 weighted score maps to rating 5: a performing single-B credit that needs full monitoring but no special handling. The rating rests on modest funded leverage, strong liquidity and a public equity cushion; it is held back by thin margins, lease intensity, permissive documents and a recovery below 50%. In the downside the score rises to 7.7 and the rating to 7 (special mention), driven by 5.34x leverage, 1.03x fixed charge coverage and a 33% diluted recovery. We would revisit the position if LTM lender EBITDA falls below $300 million, comparable sales turn negative for two quarters, or Petco incurs material pari passu incremental debt.

The paragraph under Table 8 of Compound's IC memo, unedited.

The equity cushion is the one factor the downside does not stress. It scores 6 on a 37.1% cushion in both columns, because the market value is today’s: a $2.48 share price on November 19, 2026 against a $1,914.6 million enterprise value.

What the public filings cannot tell you

Public filings give the terms, the earnings and the clauses, and they leave the borrower’s own covenant figures, the collateral reports and the trading picture as assumptions. Each item below would replace a specific assumption in the model.

  • The compliance certificate. Covenant EBITDA as Petco computes it under the agreement, with the run-rate savings it claims. The model lends against $366.0 million, and the uncapped definition can run well above that.
  • The ABL borrowing base certificate. The model holds availability at the August 1, 2026 level in the lender case, cuts it 15% in the downside and assumes the ABL is 60% drawn at default.
  • Whether the Mexico joint venture stake is pledged. The recovery counts $112.5 million for it after a 50% haircut, on the note that it “may sit outside the collateral package”.
  • Store-level results and lease expirations. The lease mitigant rests on shedding leases in a restructuring, and the filings give rent only in total.
  • Trading levels from the agent or dealers. The 100.27 mark is the BDC’s fair value at September 30, 2026, and the 100.50 cap was set against it.
  • The rating agency report itself. The B2 upgrade came from a news article, and the LSTA index figures were read from a table image on an asset manager’s weekly page.

Compound’s answer lists the lender case, the downside case, the distressed multiple, the scorecard and the hold size as its own assumptions: “Each one is labeled on the Assumptions sheet with its reason.”

Our view

The memo is one a committee can act on: the decision is on page one, the earnings adjustment is argued, and the documents section finds the clauses that matter. We would accept the rating and push harder on two points, the size of the pari passu capacity and the downside’s refinancing.

The lender EBITDA is the right base. Lending against the company’s $424.4 million would count $51.6 million of joint venture earnings that reach the borrower only as dividends, and the memo removes it from earnings while still giving the stake value in recovery. The structure section reads like a document review, with the Serta, J.Crew and Chewy protections each tested and the carve-out named.

The other side is in the memo’s own numbers. A first-lien lender recovering 47.8% in the base case, and 33.3% after a dilution the documents allow today, has thin asset cover for a senior secured position. The rating holds at 5 because liquidity and the equity cushion score well, and the cushion is the one factor the downside leaves unstressed. In the downside the first-lien debt reaches its February 2031 maturity at about 4.9x lender leverage, and the memo itself calls refinancing the binding risk.

Three things would change our view: a compliance certificate showing covenant EBITDA close to lender EBITDA, an incremental raised at a spread above the term loan’s with no MFN protection, or two more quarters of positive comparable sales. From here the work is the direct lending underwriting model for a sized commitment and a debt schedule that carries the incremental into the cases.

Petco first-lien IC credit memo (Word)Compound’s investment committee memo from this run: the recommendation and key terms on page one, the business, historical financials with each addback, the lender and downside cases, the documents, recovery, relative value, risks with mitigants and the internal risk rating, with eight tables.Download · Free Petco first-lien credit model (Excel)The workbook behind the memo: an Assumptions sheet with a source or reason beside every input, Historicals with the Adjusted EBITDA bridge, Capitalization and document capacity, the two Projections cases, Recovery, Relative Value against the BDC’s book and the loan market, the Risk Rating scorecard and Sources.Download · Free

FAQ

What goes into a private credit memo for an investment committee?

The recommendation and key terms first, then the business, historical financials with each addback, a lender case and a downside, the structure and the document terms, recovery, relative value, risks with mitigants and a rating. The memo on this page covers all of them in eight tables, and each figure ties to a workbook cell or a cited filing.

Why lend against lender EBITDA rather than the company's Adjusted EBITDA?

The company’s definition can include items a lender cannot reach or should not capitalize. Here the memo removes 50% of a joint venture’s EBITDA that Petco receives only as dividends and a one-off tariff refund, which takes $424.4 million down to $366.0 million and net leverage from 2.84x to 3.29x.

How is an internal risk rating assigned to a loan?

Score each factor against set bands, weight the scores and map the weighted score to a rating. This scorecard weights leverage 25%, business position 20%, fixed charge coverage 15% and four other factors 10% each, gives 5.8 today and 7.7 in the downside, and maps them to ratings 5 and 7.

Which credit agreement terms matter most to recovery?

The EBITDA definition, because it sizes every ratio basket; the free-and-clear and ratio incremental, because new pari passu debt shares the collateral; and the protections against non-pro-rata uptiers, IP transfers and guarantor releases. In this memo the incremental alone cuts recovery from 47.8% to 33.3%.

Can a credit memo be written from a BDC's schedule of investments?

For a borrower that files with the SEC, yes. The schedule gives the spread, maturity, par, cost and fair value, and the borrower’s credit agreement, 10-K and 10-Q give the rest. Check the two against each other: here the schedule omits the floor and shows a maturity two days earlier than the agreement.

CoatueCentri ConsultingAvra783 Capital PartnersOctahedron CapitalArix ResearchCoatueCentri ConsultingAvra783 Capital PartnersOctahedron CapitalArix ResearchCoatueCentri ConsultingAvra783 Capital PartnersOctahedron CapitalArix Research

See this workflow on your own deal

Try it now